LakeShore Biopharma (LSB) 3400 contracts of August 12.50 calls Jul 23, 2026 02:40PM
LakeShore Biopharma faces Nasdaq delisting after bid price violation Sep 12, 2025 08:00AM
LakeShore Biopharma appoints advisors for takeover proposal review Sep 10, 2025 08:10AM
LakeShore Biopharma raises $15 million in private placement Jul 8, 2025 07:26AM
LakeShore Biopharma (LSB) Regains Nasdaq Compliance Oct 29, 2024 08:34AM


Oct 25, 2024 08:30AM LakeShore Biopharma (LSB) Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
Oct 8, 2024 08:33AM LakeShore Biopharma (LSB) Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance
Sep 4, 2024 08:07AM LakeShore Biopharma (LSB) Announces Leadership Transitions